Activity Description
In this opening installment of a four-part educational series on Macular Telangiectasia Type 2 (MacTel), TFG’s expert consensus group reframes MacTel from a vascular anomaly to a primary neurodegenerative disorder centered on Müller cell dysfunction and photoreceptor loss. Faculty examine the metabolic underpinnings, review epidemiologic trends and underdiagnosis, and highlight the pathognomonic OCT findings that should raise clinical suspicion. Importantly, this episode challenges clinicians to move beyond the “Snellen trap” and consider significant functional decline, particularly difficulty reading, paracentral scotomas, and subtle central visual disturbances, as clinical signs of MacTel.
Through faculty commentary and survey data, this video clarifies why ellipsoid zone loss often precedes vision decline and why earlier recognition is critical to preserving visual function. By the end of this video, learners will better understand the neurodegenerative core of MacTel type 2 and recognize early clinical and functional red flags that warrant further multimodal evaluation.
The Fundingsland Group is accredited by the ACCME to provide continuing medical education for physicians.
Release Date: 4/30/26
Expiration Date: 4/30/27
Target Audience
This accredited educational activity is designed for ophthalmologists.
Grant Support Statement
This activity is supported by an unrestricted educational grant from Neurotech.
Faculty
